Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-25-058841
Filing Date
2025-04-25
Accepted
2025-04-25 17:00:18
Documents
19
Period of Report
2025-06-04

Document Format Files

Seq Description Document Type Size
1 DEF 14A fgen-20250425.htm   iXBRL DEF 14A 1469090
2 GRAPHIC img66612491_0.jpg GRAPHIC 249357
3 GRAPHIC img66612491_1.jpg GRAPHIC 76493
4 GRAPHIC img66612491_2.jpg GRAPHIC 74413
5 GRAPHIC img66612491_3.jpg GRAPHIC 2635823
6 GRAPHIC img66612491_4.jpg GRAPHIC 2152925
  Complete submission text file 0000950170-25-058841.txt   14563817

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT fgen-20250425.xsd EX-101.SCH 39424
22 EXTRACTED XBRL INSTANCE DOCUMENT fgen-20250425_htm.xml XML 500099
Mailing Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133
Business Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36740 | Film No.: 25875043
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)